Direkt zum Inhalt
Merck
Alle Fotos(3)

Wichtige Dokumente

Gesamtdokumentation anzeigen

C8630

Sigma-Aldrich

DL-Cystin

Synonym(e):

(±)-3,3′-Dithio-bis-(2-aminopropionsäure)

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(3)

About This Item

Lineare Formel:
HOOCCH(NH2)CH2SSCH2CH(NH2)COOH
CAS-Nummer:
923-32-0
Molekulargewicht:
240.30
Beilstein:
1728095
EG-Nummer:
213-094-5
MDL-Nummer:
MFCD00084652
UNSPSC-Code:
12352200
PubChem Substanz-ID:
24893084
NACRES:
NA.26

Assay

≥98% (TLC)

Form

powder

Farbe

white to off-white

mp (Schmelzpunkt)

227 °C (dec.) (lit.)

Löslichkeit

1 M HCl: soluble

SMILES String

NC(CSSCC(N)C(O)=O)C(O)=O

InChI

1S/C6H12N2O4S2/c7-3(5(9)10)1-13-14-2-4(8)6(11)12/h3-4H,1-2,7-8H2,(H,9,10)(H,11,12)

InChIKey

LEVWYRKDKASIDU-UHFFFAOYSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Biochem./physiol. Wirkung

DL-Cystine is a racemic mixture of the proteinogenic amino acids L-cystine and the non-proteinogenic D-cystine. DL-cystine is used in the preparation of sulfur-containing dimeric and monomeric surfactants.

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Persönliche Schutzausrüstung

Eyeshields, Gloves, type N95 (US)

Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Kunden haben sich ebenfalls angesehen

Slide 1 of 7

1 of 7

L-Cystin produced by Wacker Chemie AG, Burghausen, Germany, ≥98.5%

Sigma-Aldrich

779539

L-Cystin

Seleno-DL-cystine powder

Sigma-Aldrich

S1650

Seleno-DL-cystine

L-Cystein 97%

Sigma-Aldrich

168149

L-Cystein

L-Cystin -dihydrochlorid from non-animal source, BioReagent, suitable for cell culture, ≥98.0% dry basis

Sigma-Aldrich

C6727

L-Cystin -dihydrochlorid

L-Cystein from non-animal source, BioReagent, suitable for cell culture, ≥98%

Sigma-Aldrich

C7352

L-Cystein

Glutathion Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1359

Glutathion

DL-Dithiothreitol ≥98% (HPLC), ≥99.0% (titration)

Sigma-Aldrich

D0632

DL-Dithiothreitol

Célia M C Faustino et al.
Journal of colloid and interface science, 351(2), 472-477 (2010-08-31)
Anionic urea-based dimeric (gemini) surfactants derived from the amino acids L-cystine, D-cystine and DL-cystine, as well as monomeric surfactants derived from L-cysteine, L-methionine and L-cysteic acid were synthesized and their solution properties characterized by electrical conductivity, equilibrium surface tension, and
Maria José Alves et al.
Journal of medical microbiology, 63(Pt 3), 471-477 (2014-01-17)
A group of biofilm-producing bacteria isolated from patients with urinary tract infections was evaluated, identifying the main factors contributing to biofilm formation. Among the 156 isolates, 58 (37.2%) were biofilm producers. The bacterial species (P<0.001), together with patient's gender (P
E Patricia Owen et al.
Pediatric nephrology (Berlin, Germany), 30(4), 595-601 (2014-10-19)
The mutations responsible for cystinosis in South African patients are currently unknown. A pertinent question is whether they are similar to those described elsewhere in the world. Children who were being managed for cystinosis in the Western Cape Province of
C Mast et al.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 65(5), 623-631 (2014-11-06)
The use of glutathione (GSH) and sulfate for the detoxification of paracetamol (acetaminophen, APAP) could occur at the expense of the physiological uses of cysteine (Cys). Indeed GSH and sulfate both originate from Cys. Significant APAP-induced Cys loss could generate
Federico N Soria et al.
The Journal of clinical investigation, 124(8), 3645-3655 (2014-07-19)
During brain ischemia, an excessive release of glutamate triggers neuronal death through the overactivation of NMDA receptors (NMDARs); however, the underlying pathways that alter glutamate homeostasis and whether synaptic or extrasynaptic sites are responsible for excess glutamate remain controversial. Here
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.